Colgate-Palmolive Remains One Of The Highest-Quality Names Despite Tough End-Market Backdrop: Goldman Sachs
1. Goldman Sachs maintained a Buy rating for CL with a $106 target. 2. CL's Q4 EPS of $0.91 beat expectations but organic sales growth missed. 3. Higher inflation and lower private label sales pressured margins and sales growth. 4. Management's FY25 guidance aligns with expectations, but foreign exchange poses risks. 5. Analyst anticipates modest declines in CL stock due to weaker sales growth.